Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation

J Am Coll Cardiol. 2020 Jan 21;75(2):238-240. doi: 10.1016/j.jacc.2019.11.012.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / administration & dosage*
  • Antithrombins / administration & dosage*
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / surgery*
  • Dabigatran / administration & dosage*
  • Dabigatran / adverse effects
  • Drug Therapy, Combination
  • Female
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control
  • Humans
  • Male
  • Percutaneous Coronary Intervention / adverse effects
  • Percutaneous Coronary Intervention / trends*
  • Warfarin / administration & dosage*
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Antithrombins
  • Warfarin
  • Dabigatran